Filing Details

Accession Number:
0001209191-23-018956
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-15 17:25:08
Reporting Period:
2023-03-14
Accepted Time:
2023-03-15 17:25:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1351779 Nadav Kidron 1185 Avenue Of The Americas
New York NY 10036
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-14 100,000 $2.01 100,000 No 4 P Indirect By wholly-owned corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By wholly-owned corporation
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,053,098 Direct